Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nyrada.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: The robots are taking over biotech stock selection
Health & Biotech
October Health Winners: Uscom, Respiri lead sluggish sector, but ‘time in the market, not timing, is key’
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Health Check: Approval clock ticks as FDA accepts Telix’s brain diagnostic marketing application
News
ASX Small Caps Lunch Wrap: Local markets are lower and Albo bought a beach house
Health & Biotech
Health Check: Rats – and investors – are happy as Nyrada forges ahead with its first human trial
News
Top 10 at 11: It’s all about a new drug, uranium and Mongolian coal seam gas today
News
Market Highlights: ASML’s gloomy outlook triggers Nasdaq sell-off; as expert flags overvalued ASX stocks
Stockhead TV
Tony’s Takeaway: Biotech buffet on the ASX
News
Market Highlights: Dow Jones at record after blowout jobs report; and 5 ASX small caps to watch today
News
Rise and Shine: Everything you need to know before the ASX opens
News
Top 10 at 11: Medtech, cancer drugs and fintech are this morning’s big winners
Health & Biotech
ASX Health Stocks: Inoviq’s tech boosts early detection of Parkinson’s disease
Health & Biotech
‘Tide is turning for the healthcare sector’ – ASX biotechs making strong gains in 2024 Part 2
Health & Biotech
‘Tide is turning for the healthcare sector’ – ASX biotechs making strong gains in 2024 Part 1
Health & Biotech
The next Neuren? Nyrada chases after two big markets – stroke and traumatic brain injury
Health & Biotech
